All4Cure: A Crowdsourcing Platform for Cancer Patients
This observational study, called All4Cure, is creating an online platform where cancer patients, doctors, and scientists can share medical information and research results. The goal is to help patients better understand cancer, guide treatment decisions, and speed up cancer research. You can join if you are 18 or older, have been diagnosed with cancer, and are under a doctor's care. The study aims to enroll 5000 participants. Success will be measured by changes in tumor tissue molecular profiles (how the cancer cells look at a molecular level) over six years. The current recruitment status is unclear.
- Study design
- This is an observational study with a planned enrollment of 5000 participants. It does not involve any specific interventions or treatments.
- What's involved
- Leftover samples from patients with cancer (blood, bodily fluids, and/or tissues collected for clinical purposes) will be obtained and sent for various types of analyses.
- Compensation
- Not stated in the trial record.
- Follow-up
- Changes in tumor tissue molecular profiles will be measured at 6 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Crowd Sourcing Platform for Patients With Cancer
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Carl A Blau, MD · PRINCIPAL_INVESTIGATOR · All4Cure
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- Change in tumor tissue molecular profiles6 years
Profiles of pre- and post-treatment tumor tissue will be compared.